Fresenius Medical Care AG & Co. KGaA  / Key word(s): Final Results/Forecast

25.02.2014 06:58

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Fresenius Medical Care has achieved its targets for the financial year
2013.

Net revenue of Fresenius Medical Care AG & Co. KGaA for the full year 2013
was $14,610 million, up by 6% from the full year 2012.

Operating income (EBIT) for the full year 2013 increased by 2% to $2,256
million.

Net income attributable to shareholders of Fresenius Medical Care AG & Co.
KGaA decreased by 6% to $1,110 million. Excluding an investment gain in the
amount of $140 million in 2012, net income attributable to shareholders of
Fresenius Medical Care AG & Co. KGaA increased by 6%.

For the 17th consecutive year shareholders can expect to receive an
increased annual dividend. At the ordinary Annual General Meeting to be
held on May 15, 2014, shareholders will be asked to approve a dividend per
ordinary share of EUR0.77, an increase of 3% (2012: EUR0.75).

For the full year 2014, Fresenius Medical Care expects revenue to grow to
approximately $15.2 billion. Net income attributable to shareholders of
Fresenius Medical Care AG & Co. KGaA is expected to be between $1.0 billion
and $1.05 billion in 2014. The company initiated a global efficiency
program designed to enhance the company's performance over a multi-year
period. Potential cost savings before income taxes of up to $60 million
generated from this program are not included in the outlook for 2014.

Fresenius SE & Co. KGaA holds approximately 30.5% of Fresenius Medical Care
AG & Co. KGaA's capital.

Fresenius Medical Care AG & Co. KGaA
Represented by Fresenius Medical Care Management AG 
Represented by its Management Board 
Bad Homburg v.d.H., February 25, 2014


25.02.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
Phone:        +49 (0) 6172- 609 2525
Fax:          +49 (0) 6172- 609 2301
E-mail:       ir@fmc-ag.com
Internet:     www.fmc-ag.de
ISIN:         DE0005785802, DE0005785836, 
WKN:          578580, 578583
Indices:      DAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
              Terminbörse EUREX; NYSE
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------